MedTrace Logo

The Efficacy Evaluation of Buckwheat Husk Extract on Cardiovascular Disease Risk Factors

NCT04490720 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-01-09

No results posted yet for this study

Summary

To assess the efficacy evaluation of buckwheat husk extract on cardiovascular disease risk factors

Conditions

Interventions

DIETARY_SUPPLEMENT

Placebo

consume 1 sachet per day for 2 months

DIETARY_SUPPLEMENT

Buckwheat husk extract

consume 1 sachet per day for 2 months

Sponsors & Collaborators

  • TCI Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Mao-Hsin Lin, Doctor · National Taiwan University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-24
Primary Completion
2025-12-31
Completion
2026-02-28

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04490720 on ClinicalTrials.gov